| Mon, 18 Mar 2019 13:50:02: | Dermira soars as Dupixent challenger hits midphase endpoint
|
| Mon, 18 Mar 2019 13:12:42: | Aerpio shares plummet on eye study flop
|
| Mon, 18 Mar 2019 12:21:31: | Unlocking a secret of the anti-cancer gene p53
|
| Mon, 18 Mar 2019 11:18:08: | Imara lands $63M crossover round to trial sickle cell drug
|
| Mon, 18 Mar 2019 09:50:42: | After a hiring blitz, Karuna nabs $68M funding round
|
| Mon, 18 Mar 2019 09:17:40: | Allergy Therapeutics’ shares nose-dive as another setback hits the biotech
|
| Fri, 15 Mar 2019 11:39:55: | FDA delays Karyopharm PDUFA to review extra information
|
| Fri, 15 Mar 2019 10:55:34: | Gottlieb criticizes sponsors’ ‘continued reluctance’ to rethink clinical trials
|
| Thu, 14 Mar 2019 17:01:46: | Chutes & Ladders—Novartis' Sandoz chief exits, fueling spinoff and sale rumors
|
| Thu, 14 Mar 2019 13:39:40: | C4 poaches new CMO after signing $900M clinical development deal with Roche
|
| Thu, 14 Mar 2019 12:55:41: | Esperion shares yo-yo as NEJM papers downplay cancer death data
|
| Thu, 14 Mar 2019 11:23:48: | Germany joins CARB-X, commits €40M to fighting bacteria
|
| Thu, 14 Mar 2019 10:57:34: | Using Pfizer’s smoking-cessation treatment Chantix to control neurons for drug research
|
| Wed, 13 Mar 2019 13:25:37: | Karuna hires another ex-Lilly scientist in quest to resurrect CNS drug
|
| Wed, 13 Mar 2019 10:20:59: | BioNTech lines up $800M Nasdaq IPO to fuel mRNA R&D: Reuters
|
| Wed, 13 Mar 2019 09:53:11: | New insights emerge in an effort to repurpose Novartis’ cancer drug Tasigna in Parkinson’s disease
|
| Wed, 13 Mar 2019 00:15:43: | New enzyme boosts 'CRISPR toolbox' for disease detection
|
| Tue, 12 Mar 2019 18:21:33: | With NCI Director Sharpless in as interim FDA head, what does that mean for interagency cooperation?
|
| Tue, 12 Mar 2019 14:03:18: | Trump’s budget plan puts squeeze on NIH, boosts FDA
|
| Tue, 12 Mar 2019 13:57:08: | Microsoft partners with biotech on ‘biological computing’ and cell DNA programming
|
| Tue, 12 Mar 2019 12:43:26: | Startup Tiburio nabs Avrobio executive Kreher as chief medical officer
|
| Tue, 12 Mar 2019 09:47:59: | EMA opens Amsterdam office as Brexit enters critical phase
|
| Tue, 12 Mar 2019 09:04:42: | AstraZeneca taps microbiome specialist Seres for I-O support
|
| Mon, 11 Mar 2019 13:16:05: | IBM uses machine learning to detect early Alzheimer’s in blood samples
|
| Mon, 11 Mar 2019 13:09:03: | Stemline licenses RET inhibitor from U.K. cancer group
|
